Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5489)
Tempus AI, Inc. (TEM)
Polovin Andrew — EVP, Chief Legal Officer
Shares
22,148
Price
$49.61
Total Value
$1.10M
Shares Held After
146,067
% of Holdings
13.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
132,591
Price
$49.61
Total Value
$6.58M
Shares Held After
2,098,130
% of Holdings
5.9%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
41,095
Price
$49.61
Total Value
$2.04M
Shares Held After
562,463
% of Holdings
6.8%
Tempus AI, Inc. (TEM)
Schoenherr Thomas Edward — CEO, Diagnostics
Shares
9,232
Price
$49.61
Total Value
$458.00K
Shares Held After
97,797
% of Holdings
8.6%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
186
Price
$71.98
Total Value
$13.39K
Shares Held After
9,570
% of Holdings
1.9%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
418
Price
$71.98
Total Value
$30.09K
Shares Held After
54,627
% of Holdings
0.8%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
2,199
Price
$25.00
Total Value
$54.98K
Shares Held After
819,214
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
HERSHBERG ROBERT — Director
Shares
15,664
Price
$24.41
Total Value
$382.36K
Shares Held After
46,683
% of Holdings
25.1%
Adaptive Biotechnologies Corp (ADPT)
HERSHBERG ROBERT — Director
Shares
15,000
Price
$24.39
Total Value
$365.85K
Shares Held After
62,347
% of Holdings
19.4%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
918
Price
$5.08
Total Value
$4.67K
Shares Held After
3,180,394
% of Holdings
0.0%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
1,000
Price
$5.15
Total Value
$5.15K
Shares Held After
3,179,476
% of Holdings
0.0%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
1,000
Price
$5.14
Total Value
$5.14K
Shares Held After
3,178,476
% of Holdings
0.0%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
1,000
Price
$5.11
Total Value
$5.11K
Shares Held After
3,177,476
% of Holdings
0.0%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
1,000
Price
$5.10
Total Value
$5.10K
Shares Held After
3,176,476
% of Holdings
0.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
253,080
Price
$0.38
Total Value
$96.17K
Shares Held After
7,914,126
% of Holdings
3.1%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
1,830
Price
$0.38
Total Value
$695.40
Shares Held After
55,663
% of Holdings
3.2%
Heartflow, Inc. (HTFL)
Farquhar John C.M. — Director
Shares
32,676
Price
$45.00
Total Value
$1.47M
Shares Held After
388,044
% of Holdings
7.8%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
45,090
Price
$0.38
Total Value
$17.13K
Shares Held After
1,411,974
% of Holdings
3.1%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
253,080
Price
$0.38
Total Value
$96.17K
Shares Held After
7,914,126
% of Holdings
3.1%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
1,830
Price
$0.38
Total Value
$695.40
Shares Held After
55,663
% of Holdings
3.2%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
45,090
Price
$0.38
Total Value
$17.13K
Shares Held After
1,411,974
% of Holdings
3.1%
Orthofix Medical Inc. (OFIX)
Fisher Patrick — President, Global Limb Recon
Shares
1,295
Price
$10.09
Total Value
$13.07K
Shares Held After
51,219
% of Holdings
2.5%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
OLUKOTUN ADEOYE Y — Director
Shares
2,000
Price
$86.96
Total Value
$173.92K
Shares Held After
31,600
% of Holdings
6.0%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
2,293
Price
$3.38
Total Value
$7.75K
Shares Held After
1,056,594
% of Holdings
0.2%
Cigna Group (CI)
Jones Nicole S — EVP, Chief Administrative Officer and Chief Human Resources Officer
Shares
2,677
Price
$279.61
Total Value
$748.52K
Shares Held After
25,880
% of Holdings
9.4%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
PERRY MICHAEL S — Director
Shares
11,600
Price
$87.30
Total Value
$1.01M
Shares Held After
111,459
% of Holdings
9.4%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
3,481
Price
$338.50
Total Value
$1.18M
Shares Held After
2,301,375
% of Holdings
0.2%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
16,243
Price
$337.63
Total Value
$5.48M
Shares Held After
2,304,856
% of Holdings
0.7%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
109,425
Price
$336.43
Total Value
$36.81M
Shares Held After
2,321,099
% of Holdings
4.5%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
131,752
Price
$335.64
Total Value
$44.22M
Shares Held After
2,430,524
% of Holdings
5.1%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
25,536
Price
$334.94
Total Value
$8.55M
Shares Held After
2,562,276
% of Holdings
1.0%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
8,404
Price
$333.82
Total Value
$2.81M
Shares Held After
2,587,812
% of Holdings
0.3%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
2,920
Price
$332.69
Total Value
$971.47K
Shares Held After
2,596,216
% of Holdings
0.1%
STRYKER CORP (SYK)
STRYKER RONDA E — Director
Shares
2,239
Price
$331.74
Total Value
$742.77K
Shares Held After
2,599,136
% of Holdings
0.1%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
631
Price
$3.38
Total Value
$2.13K
Shares Held After
673,853
% of Holdings
0.1%
ILLUMINA, INC. (ILMN)
Wedel Christensen Jakob — SVP, Strategy/Corp Development
Shares
1,033
Price
$191.52
Total Value
$197.84K
Shares Held After
14,023
% of Holdings
6.9%
Acrivon Therapeutics, Inc. (ACRV)
Miller Mary — Chief Legal Officer
Shares
185
Price
$2.01
Total Value
$371.85
Shares Held After
82,009
% of Holdings
0.2%
Acrivon Therapeutics, Inc. (ACRV)
Blume-Jensen Peter — Director
Shares
484
Price
$2.01
Total Value
$972.84
Shares Held After
385,859
% of Holdings
0.1%
Acrivon Therapeutics, Inc. (ACRV)
Blume-Jensen Peter — Director
Shares
1,229
Price
$2.01
Total Value
$2.47K
Shares Held After
2,244,088
% of Holdings
0.1%
Keros Therapeutics, Inc. (KROS)
Lerner Lorena Raquel — Chief Scientific Officer
Shares
3,568
Price
$10.29
Total Value
$36.71K
Shares Held After
27,559
% of Holdings
11.5%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
2,000
Price
$122.58
Total Value
$245.16K
Shares Held After
214,678
% of Holdings
0.9%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
6,296
Price
$121.01
Total Value
$761.86K
Shares Held After
216,678
% of Holdings
2.8%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
12,917
Price
$119.86
Total Value
$1.55M
Shares Held After
222,974
% of Holdings
5.5%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
4,500
Price
$119.04
Total Value
$535.68K
Shares Held After
235,891
% of Holdings
1.9%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
8,868
Price
$117.70
Total Value
$1.04M
Shares Held After
240,391
% of Holdings
3.6%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
10,420
Price
$116.82
Total Value
$1.22M
Shares Held After
249,259
% of Holdings
4.0%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
33,354
Price
$115.90
Total Value
$3.87M
Shares Held After
259,679
% of Holdings
11.4%
Acrivon Therapeutics, Inc. (ACRV)
Devroe Eric — Chief Operating Officer
Shares
604
Price
$2.01
Total Value
$1.21K
Shares Held After
146,349
% of Holdings
0.4%
Acrivon Therapeutics, Inc. (ACRV)
Gamelin Erick — Chief Development Officer
Shares
400
Price
$2.01
Total Value
$804.00
Shares Held After
52,592
% of Holdings
0.8%
Keros Therapeutics, Inc. (KROS)
Newton Charles W. — Director
Shares
551
Price
$10.30
Total Value
$5.68K
Shares Held After
12,114
% of Holdings
4.4%
Showing 101–150 of 5489 transactions (page 3 of 110)